CAMP Q1 2023 Earnings — CAMP4 Therapeutics Corporation Revenue & Financial Results | Market Cap Arena

CAMPCAMP4 Therapeutics Corporation

$125M

Q1 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$79M+14.8% YoY

Gross Profit

$28M35.3% margin

Operating Income

-$2M-2.0% margin

Net Income

-$8M-10.3% margin

EPS (Diluted)

$-0.22

QoQ Revenue Growth

-0.5%

Cash Flow

Operating Cash Flow

-$1M

Free Cash Flow

-$1M

Stock-Based Comp.

$774,500

Balance Sheet

Total Assets

$380M

Total Liabilities

$366M

Stockholders' Equity

$14M

Cash & Equivalents

$42M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$79M	$68M	+14.8%
Gross Profit	$28M	$28M	-1.1%
Operating Income	-$2M	-$4M	+64.3%
Net Income	-$8M	-$9M	+11.9%

Revenue Segments

Product

$50M64%

Application Subscriptions And Other Services

$28M36%

Geographic Segments

UNITED STATES

$48M76%

Latin America

$9M14%

Asia Pacific

$5M8%

All Other

$1M2%